- Home
- MNY vs LVTX Comparison
MNY vs LVTX Comparison
Compare MNY & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNY
- LVTX
- Stock Information
- Founded
- MNY 2014
- LVTX 2016
- Country
- MNY Singapore
- LVTX Netherlands
- Employees
- MNY N/A
- LVTX N/A
- Industry
- MNY
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- MNY
- LVTX Health Care
- Exchange
- MNY Nasdaq
- LVTX Nasdaq
- Market Cap
- MNY 43.9M
- LVTX 40.0M
- IPO Year
- MNY N/A
- LVTX 2021
- Fundamental
- Price
- MNY $1.13
- LVTX $1.48
- Analyst Decision
- MNY Strong Buy
- LVTX Hold
- Analyst Count
- MNY 1
- LVTX 4
- Target Price
- MNY $4.00
- LVTX $1.58
- AVG Volume (30 Days)
- MNY 286.9K
- LVTX 345.0K
- Earning Date
- MNY 09-19-2025
- LVTX 08-13-2025
- Dividend Yield
- MNY N/A
- LVTX N/A
- EPS Growth
- MNY N/A
- LVTX N/A
- EPS
- MNY N/A
- LVTX N/A
- Revenue
- MNY $68,997,746.00
- LVTX $4,990,000.00
- Revenue This Year
- MNY $15.76
- LVTX N/A
- Revenue Next Year
- MNY $20.60
- LVTX N/A
- P/E Ratio
- MNY N/A
- LVTX N/A
- Revenue Growth
- MNY N/A
- LVTX N/A
- 52 Week Low
- MNY $0.55
- LVTX $0.85
- 52 Week High
- MNY $2.40
- LVTX $2.09
- Technical
- Relative Strength Index (RSI)
- MNY 32.34
- LVTX 37.91
- Support Level
- MNY $1.35
- LVTX $1.53
- Resistance Level
- MNY $1.49
- LVTX $1.59
- Average True Range (ATR)
- MNY 0.12
- LVTX 0.06
- MACD
- MNY -0.02
- LVTX -0.01
- Stochastic Oscillator
- MNY 19.39
- LVTX 25.00
About MNY MoneyHero Limited
MoneyHero Ltd is a personal finance aggregation and comparison company in Greater Southeast Asia. The firm is involved in the operation of online financial comparison platforms and related services for credit cards, personal loans, mortgages, insurance, and other financial products, connecting the providers of these products with well-matched and ready-to-transact consumers and generating revenue directly from these providers for placing their products on its platforms and providing insurance brokerage, marketing and events-related services. Geographically it operates in Singapore, Hong Kong, Taiwan, Malaysia and the Philippines.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.